Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Plitidepsin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaMar says potential COVID-19 treatment shows efficacy against Omicron
    PharmaMar says potential COVID-19 treatment shows efficacy against Omicron

    10 Jan 2022

    // Inti Landauro REUTERS

    https://www.reuters.com/markets/europe/spains-pharmamar-says-potential-covid-19-treatment-shows-efficacy-against-2022-01-11/

    Inti Landauro REUTERS
    10 Jan 2022
    Share Share
    PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
    PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19

    29 Jan 2021

    // Lucy Parsons PMLIVE

    http://www.pmlive.com/pharma_news/pharmamars_cancer_drug_has_potent_preclinical_efficacy_against_covid-19_1362250

    Lucy Parsons PMLIVE
    29 Jan 2021
    Share Share
    PharmaMar plans phase III trial of cancer drug for COVID-19, shares jump
    PharmaMar plans phase III trial of cancer drug for COVID-19, shares jump

    15 Oct 2020

    // Emma Pinedo REUTERS

    https://www.reuters.com/article/us-health-coronavirus-spain-pharmamar/pharmamar-plans-phase-iii-trial-of-cancer-drug-for-covid-19-shares-jump-idUSKBN2710Y6

    Emma Pinedo REUTERS
    15 Oct 2020
    Share Share
    Boryung , PharmaMar’s partner in South Korea, announces superior potent results
    Boryung , PharmaMar’s partner in South Korea, announces superior potent results

    02 Jul 2020

    // PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07/PR_PLITIDEPSIN_IN_VITRO_RESULTS_KOREA_OK

    http://pharmamar.com/wp-content/uploads/2020/07/PR_plitidepsin_in_vitro_results_Korea_OK.pdf

    PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07/PR_PLITIDEPSIN_IN_VITRO_RESULTS_KOREA_OK
    02 Jul 2020
    Share Share
    Scientists Tested 47 Existing Drugs And Found Potential New Ways to Fight Covid
    Scientists Tested 47 Existing Drugs And Found Potential New Ways to Fight Covid

    04 May 2020

    // N. KROGAN SCIENCEALERT

    https://www.sciencealert.com/there-are-nearly-50-already-approved-drugs-that-could-help-us-fight-covid-19

    N. KROGAN SCIENCEALERT
    04 May 2020
    Share Share
    PharmaMar Has Announced That the Spanish Medicines Agency Aplidin® (Plitidepsin)
    PharmaMar Has Announced That the Spanish Medicines Agency Aplidin® (Plitidepsin)

    29 Apr 2020

    // YAHOO

    https://www.yahoo.com/lifestyle/pharmamar-announced-spanish-medicines-agency-103500242.html

    YAHOO
    29 Apr 2020
    Share Share